Skip to main content
. 2023 Nov 15;21:426. doi: 10.1186/s12951-023-02175-9

Fig. 6.

Fig. 6

M-FNM boosted antitumor immunity. (A) Schematic illustration of immune cells infiltration. (B) IL-1β and (C) TNF-α level in mouse serum after treatments. (D) Infiltration of CD11c-labeled dendritic cells, CD8/CD4-labeled T lymphocytes, Foxp3-labeled Treg cells in tumor tissue. (E-H) Quantitative analysis of fluorescence intensity of various indicators. Compare to control, *P < 0.05, **P < 0.01, and ***P < 0.001